Clinical observation of mucoregulatory agents' application after chronic rhinosinusitis surgery.
- Author:
Jianjun SUN
1
;
Jin QIAN
;
Jing ZHAO
;
Liang LIU
Author Information
1. Department of Center of Otorhinolaryngology of PLA, Navy General Hospital, Beijing, 100048, China.
- Publication Type:Journal Article
- MeSH:
Adolescent;
Adult;
Aged;
Ambroxol;
therapeutic use;
Chronic Disease;
Cyclohexanols;
therapeutic use;
Cyclohexenes;
therapeutic use;
Eucalyptol;
Expectorants;
therapeutic use;
Female;
Humans;
Intraoperative Period;
Limonene;
Male;
Middle Aged;
Monoterpenes;
therapeutic use;
Sinusitis;
drug therapy;
Terpenes;
therapeutic use;
Treatment Outcome;
Young Adult
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2011;25(20):922-924
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the effect of mucoregulatory agents during endoscopic sinus surgery.
METHOD:Ninety-seven cases with chronic rhinosinusitis were randomly divided into three groups, with 31 cases in B group treated by ambroxol, 33 cases in C group treated by eucalyptol-limonene-pinene enteric soft capsule and 33 cases in control group (A group). The follow-up visit lasted for 6 months for three groups. Then, the therapeutic effects were evaluated and compared among these three groups.
RESULT:By the end of 6 months after treatment,the effective rate was 90.3% and 97.0% for cases in the B and C groups respectively, and only 75.8% in A group. The difference between A and C was statistically significant (P < 0.05).
CONCLUSION:Eucalyptol-limonene-pinene enteric soft capsule,as a multicomponent mucoregulatory agent, can obviously improve the secretion of mucosa and epithelial recovery, thus accelerate healing of the disease. It can also improve the success rate of functional endoscope sinus surgery, and may play a promising role in clinical application.
